Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascularization, Choroidal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00729846
What this trial is testing

Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)

Who this might be right for
Age Related Macular DegenerationChoroidal NeovascularizationMacular Edema
California Retina Consultants 22
Not applicableUnknownNCT04245072
What this trial is testing

Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis

Who this might be right for
Chorioretinitis
The Filatov Institute of Eye Diseases and Tissue Therapy 100
Not applicableUnknownNCT05222633
What this trial is testing

Anti-VEGF in Real-world

Who this might be right for
Neovascular Age-related Macular EdemaDiabetic Macular EdemaChoroidal Neovascular Membrane+3 more
Wenbin Wei 1,000
Testing effectiveness (Phase 2)Ended earlyNCT00766337
What this trial is testing

Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
Santen Inc. 62
Not applicableUnknownNCT00383812
What this trial is testing

Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Asan Medical Center 20
Post-approval studies (Phase 4)Study completedNCT03409250
What this trial is testing

SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia

Who this might be right for
Choroidal NeovascularizationAge Related Macular Degeneration
Vista Klinik 20
Not applicableStudy completedNCT02287298
What this trial is testing

Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment

Who this might be right for
Exudative Macular Degeneration
The Retina Center of St. Louis County, PC 400
Large-scale testing (Phase 3)UnknownNCT02727881
What this trial is testing

Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD

Who this might be right for
Age-related Macular Degeneration
Ohr Pharmaceutical Inc. 230
Testing effectiveness (Phase 2)Ended earlyNCT02228304
What this trial is testing

Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Neurotech Pharmaceuticals 42
Testing effectiveness (Phase 2)Study completedNCT01242254
What this trial is testing

A Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 36
Early research (Phase 1)UnknownNCT01217762
What this trial is testing

Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular DegenerationWet Age-Related Macular DegenerationMacular Degeneration+2 more
Oraya Therapeutics, Inc. 62
Post-approval studies (Phase 4)Study completedNCT01950741
What this trial is testing

Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy

Who this might be right for
Exudative Age-related Macular DegenerationPolypoidal Choroidal Vasculopathy
Pusan National University Hospital 48
Testing effectiveness (Phase 2)Study completedNCT00043680
What this trial is testing

Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 60
Post-approval studies (Phase 4)Not Yet RecruitingNCT07187804
What this trial is testing

Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization

Who this might be right for
Age-related Macular Degeneration (ARMD)Choroidal NeovascularizationAnti-vascular Endothelial Growth Factor
Kim's Eye Hospital 30
Not applicableUnknownNCT04119219
What this trial is testing

Antiangiogenic Therapy of CNV Associated With Angioid Streaks

Who this might be right for
Angioid Streaks of Macula
The Filatov Institute of Eye Diseases and Tissue Therapy 100
Not applicableStudy completedNCT03459144
What this trial is testing

Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen

Who this might be right for
Polypoidal Choroidal Vasculopathy
Sun Yat-sen University 60
Testing effectiveness (Phase 2)UnknownNCT02857517
What this trial is testing

Intravitreal Conbercept for Idiopathic Choroidal Neovascularization

Who this might be right for
Idiopathic Choroidal Neovascularization
Jiao Mingfei 50
Early research (Phase 1)Study completedNCT00008515
What this trial is testing

Fluocinolone Implant to Treat Macular Degeneration

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
National Eye Institute (NEI) 16
Early research (Phase 1)UnknownNCT00855608
What this trial is testing

Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study

Who this might be right for
UveitisDiabetic RetinopathyChoroidal Neovascularization
Rafic Hariri University Hospital 15
Testing effectiveness (Phase 2)Ended earlyNCT03452527
What this trial is testing

Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationWet Macular Degeneration
Iconic Therapeutics, Inc. 15
Next Page